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The COVID-19 pandemic has put a stop to the continuous progression in life expectancy at birth, in which Spain was one of 
the world leaders. Although this downward effect is a result of the present conjuncture and it is hoped that recovery will be 
swift in the coming years, this situation has led us to consider the evolution prior to the pandemic. It is true that the increase 
in number of years of life has been progressive and steady but, in recent years, these gains have not implied improved health 
among the older population. Disability-free life expectancy at the age of 65 has been very stable over time, but the figures are 
less encouraging when the presence of diseases and chronic conditions are taken into account. In this issue of Perspectives 
Demogràfiques, we investigate whether there have been gains or losses in years of disease-free life for men and women at the 
age of 65 in Spain and by autonomous community (AC) in the years 2006, 2012, and 2017. The results indicate that increased 
life expectancy will also mean that people will live more time with diagnosed diseases unless the present trend is reversed. The 
most common ailments and conditions include hypertension, chronic back pain, diabetes, and heart disease. The differences 
between men and women tend to converge in years of life in good health, mainly as a result of a lengthening of time lived in 
poor health among men.
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LIFE EXPECTANCY AND INCREASED TIME LIVED WITH DISEASES
Life expectancy in Spain is currently among the highest in the world, with 80.9 years for men and 86.2 for women in 2019. This positive 
growth has been observed uninterruptedly since the 1970s. However, one must also ask whether these gains in terms of lifespan also include 
good health, especially among the older population. According to data from the National Statistics Institute (INE), life expectancy in good 
health at birth has increased in the last 15 years, yet the number of years lived in good health after the age of 65 have remained quite stable 
despite increased life expectancy (INE, 2020). The most common measure for defining good health is based on the absence of functional 
limitations or disabilities. Yet, it is important to know what happens with other health indicators, establishing how much of our lives we will 
spend with chronic diseases or adverse conditions of health. This perspective is relevant because chronic diseases are a major determinant 
of quality of life. They are related with 
many health problems, they increase the 
risk of dying younger, and they define the 
level of use and the kinds of interventions 
carried out by health services.
Increased life expectancy results from 
health improvements that delay death. If 
death is deferred at the same pace as the 
age of onset of disease or health problems, 
what is called extension of morbidity occurs 
or, in other words, people live more years 
in bad health. However, if the age at which 
diseases appear is delayed, two things 
might happen. First, if this age increases 
more slowly than life expectancy, extension 
of morbidity would once again be the result. 
But if age at the onset of health problems is 
FIGURE 1. Evolution of life expectancy at the age of 65 and years lived with and without disease
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delayed faster than the increase in life expectancy, there would be 
a compression of morbidity, which would be more concentrated in 
the last years of life. Data from national health surveys combined 
with data of mortality by age enable us to investigate whether 
there has been compression or expansion of morbidity in Spain in 
recent years—that is to say whether the amount of time lived in bad 
health has increased or decreased. Hence, we can calculate the time 
of life expectancy with chronic illness or health conditions after 
the age of 65 for Spain and determine whether this is distributed 
differently among the ACs. Given the differences between the sexes 
in mortality and morbidity, we shall analyse the recent evolution 
separately for men and women. We use data from the national 
health surveys of 2006, 2012, and 2017 in which we investigate the 
presence of health problems including asthma, cancer, diabetes, 
stroke, hypertension, myocardial infarction, heart disease, chronic 
obstructive pulmonary disease (COPD), and chronic back pain, 
while bearing in mind that most of them are related with COVID-19 
mortality. We use what is known as Sullivan’s method which is 
based on applying the proportions of individuals with one of the 
selected health problems to a life table. The calculation, based 
on specific observations, by sex and five-year age groups, of the 
presence of disease and deaths makes it possible to obtain the 
time of life expectancy (after a certain age) lived with each of the 
conditions, with at least one of them, or without any.
Figure 1 shows the evolution of life expectancy at 65 years for men 
and women between 2006 and 2017 together with the evolution of 
life expectancy at this age with at least one of the specified health 
problems. Life expectancy shows lineal growth from 17.7 to 19.1 
years for men, and from 21.7 to 23.0 years for women. At the same 
time, the number of disease-free years 
shows a more stable evolution with 
a slight rise between 2006 and 2012, 
after which it drops again between 2012 
and 2017, although always remaining 
at about 5 years for men and a little 
less for women. Additionally, while the 
number of years lived with at least one 
health problem has risen at a slow rate 
between 2006 and 2012 it has shown 
a greater increase between 2012 and 
2017, especially among men. As for 
differences by sex, women consistently 
show a higher life expectancy than men 
in all the years. However, when we 
observe the evolution of years lived in 
good health, we confirm that there is convergence between the two 
sexes where, in 2006, men lived more years without these health 
problems, but in 2017 the time lived in good health was comparable 
to that for women. In any case, since women have a greater life 
expectancy than men, the time lived with health problems is also 
longer for them throughout this period. Despite the years of life 
gained between 2006 and 2017—1.3 for men and 1.4 for women—
men have lost 0.4 disease-free years (-26.7% of the rise in life 
expectancy) and women have gained 0.3 years (23.9% of their 
increase). But the impact and evolution of the diseases has not been 
the same for men and women.
GENDER DIFFERENCES IN THE TIME LIVED 
WITH EACH DISEASE
This study covers nine health conditions that are especially 
relevant for different reasons. Cancer and cardiovascular and 
cerebrovascular diseases (stroke, myocardial infarction, and other 
heart diseases) were among the five main causes of death in Spain 
during the period analysed. Moreover, we have considered two 
health problems that are cardiovascular risk factors (hypertension 
and diabetes), as well as including back pain (chronic lumbar and 
cervical pain), which was the main factor associated with years lived 
with disability in Spain in 2016. Finally, we have also examined 
asthma and chronic obstructive pulmonary disease (COPD), the 
two most frequent respiratory diseases. By contrast, inclusion of 
high cholesterol has been ruled out because part of the observed 
increase is due to the change in diagnostic parameters in the period 
between the different health surveys. Neither has it been possible 
to include other diseases that cause functional impairment (like 
FIGURE 2. Evolution of the proportion of life expectancy at the age of 65 lived with each disease, 
by sex
Source: INE and ENSE 2006, 2012, 2017
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osteoarthritis) because of an absence of comparability between the 
surveys. Some of the health conditions we have taken into account 
are not only the chief causes of mortality and the burden of illness 
and disability, but they are also risk factors associated with the 
severity of COVID-19 and the resulting hospitalisation. When we 
analyse each of the diseases and health conditions separately, we 
can see in Figure 2 which ones have the greatest impact on the 
time lived in poor health, and if there are differences due to sex. 
Suffering from hypertension is the most common health condition. 
In the age group of over 65, men lived 9.6 years with this in 2017, 
and women 12.3 years, which represents 53.6% and 50.1% of time 
left to live for men and women respectively. Having chronic back 
pain was the next most prevalent condition, especially for women, 
and it accounts for 28.2% of life expectancy at the age of 65 for men 
and 48.0% for women in 2017.
With many of the diseases it is possible to observe a sustained 
increase in life expectancy lived with the ailment (hypertension 
only for men, heart disease only for women, and chronic back pain, 
diabetes, and cancer for men and women) but the increase has been 
especially significant because of hypertension and diabetes among 
men. The evolution has been different with other diseases (asthma 
for men and women, heart disease for men, and hypertension and 
myocardial infarction for women), for which the proportion of time 
lived with the disease has diminished or remained steady between 
2006 and 2012 but has risen between 2012 and 2017. In the case 
of COPD, it increased in 2012 and decreased in 2017 for both men 
and women. Finally, some diseases have shown a decrease in the 
proportion of time lived with them between 2006 and 2017 (stroke 
for both men and women and, for men, myocardial infarction as 
well). In the case of these two latter health conditions, and also that 
of COPD, compression of morbidity is observed.
EVOLUTION AND HETEROGENEITY IN THE 
ACS: CROSSING PATHS BETWEEN MEN 
AND WOMEN
Both life expectancy and years lived with good or bad health 
present variability at the AC level. Figure 3 shows the 
distribution of the different indicators among the 17 ACs 
studied, separated by sex and year. Life expectancy is more 
consistent and there is less variation between regions, with a 
progressive increase everywhere. As for life expectancy with at 
least one disease, and disease-free life expectancy, heterogeneity 
is present in all years and is lower in 2012 for men and in 2006 
for women but, in both cases, 2017 seems to be the year when 
the differences between the ACs have increased to the greatest 
extent. This rise in heterogeneity of life expectancy with at 
least one disease at the age of 65 is reflected in a difference of 
values among the ACs of 5.2 years for men and 5.4 years for 
women whereas, in 2006, the difference was only 4.0 years 
for men and 3.3 years for women. In many ACs, as a result of 
steady figures and a slight decrease in the amount of time lived 
without diseases, especially among men, there has been a rise 
in the number of years lived with one or more diseases between 
2006 and 2017. In the case of years lived in good health, the 
convergent evolution between the sexes means that, by 2017, 
the situation of women had become equal to or better than 
that of men in most of the ACs, reproducing the results at the 
national level.
FIGURE 3. Regional heterogeneity of changes in life expectancy at 
the age of 65
Source: INE and ENSE 2006, 2012, 2017 
Note: All ACs included but the Autonomous Cities of Ceuta and Melilla.
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MORBIDITY COMPRESSION: A PRIORITY 
GOAL
Reversing the tendency where prolonged life expectancy at 
advanced ages is accompanied by stagnation in terms of years 
of healthy life should be a priority goal of the health system in 
the coming years. After the age of 65, the presence of diseases 
and health problems has not diminished since 2006, which has 
led to a greater number of years lived in bad health, especially 
among men. Having hypertension, chronic back pain, diabetes, 
and heart diseases are the most common conditions for 
men and women. And, for the great majority of diseases and 
conditions considered, the time lived with them has remained 
unchanged or has increased. Moreover, this stagnation with 
regard to improvements in the number of years lived in good 
health has been more pronounced between 2012 and 2017, a 
period in which the differences between the ACs also widened. 
A very diverse range of factors explains this trend. To begin 
with, improvements in the health system have focused more on 
dealing with acute cases closer to death, which leads to a better 
survival rate but also to a greater number of individuals living 
with diseases or health problems. Furthermore, diet has been 
steadily worsening in the last few years throughout the whole 
population and this, together with a decline in physical activity, 
has caused an increase in the body mass index (Basterra-Gortari 
et al., 2017), which inevitably has negative consequences in the 
prevalence of diseases and health problems like hypertension, 
diabetes, heart diseases, stroke, and cancer. However, these 
trends have not occurred in a similar way over the territory, 
which suggests that policies aimed at improving the health of 
the older people could be implemented. Furthermore, there are 
significant differences between men and women, most notably 
the fact that, in recent years, men have shown more pronounced 
stagnation with regard to their health than women have. This 
evolution could be behind the apparent paradox of the greater 
incidence and severity of COVID-19 in the male population. 
Women are more exposed to infection due to their prevalence 
in care work, their larger presence in the health sector, and the 
feminisation of old age. Nevertheless, the greater imbalance in 
the worsening of diseases that has come with the gains of longer 
life among men found in this study would shed some light on 
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